| Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer JS Miller, Y Soignier, A Panoskaltsis-Mortari, SA McNearney, GH Yun, ... Blood 105 (8), 3051-3057, 2005 | 2059 | 2005 |
| Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics CG Brunstein, JS Miller, Q Cao, DH McKenna, KL Hippen, J Curtsinger, ... Blood, The Journal of the American Society of Hematology 117 (3), 1061-1070, 2011 | 1254 | 2011 |
| Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs DG Phinney, M Di Giuseppe, J Njah, E Sala, S Shiva, CM St Croix, ... Nature communications 6 (1), 8472, 2015 | 887 | 2015 |
| Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial JG Wilson, KD Liu, H Zhuo, L Caballero, M McMillan, X Fang, K Cosgrove, ... The Lancet Respiratory Medicine 3 (1), 24-32, 2015 | 766 | 2015 |
| Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial MA Matthay, CS Calfee, H Zhuo, BT Thompson, JG Wilson, JE Levitt, ... The Lancet Respiratory Medicine 7 (2), 154-162, 2019 | 563 | 2019 |
| Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices RR Sharma, K Pollock, A Hubel, D McKenna Transfusion 54 (5), 1418-1437, 2014 | 507 | 2014 |
| A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer MA Geller, S Cooley, PL Judson, R Ghebre, LF Carson, PA Argenta, ... Cytotherapy 13 (1), 98-107, 2011 | 497 | 2011 |
| Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein V Bachanova, S Cooley, TE Defor, MR Verneris, B Zhang, DH McKenna, ... Blood, The Journal of the American Society of Hematology 123 (25), 3855-3863, 2014 | 447 | 2014 |
| Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect CG Brunstein, JS Miller, DH McKenna, KL Hippen, TE DeFor, D Sumstad, ... Blood, The Journal of the American Society of Hematology 127 (8), 1044-1051, 2016 | 420 | 2016 |
| Massive ex vivo expansion of human natural regulatory T cells (Tregs) with minimal loss of in vivo functional activity KL Hippen, SC Merkel, DK Schirm, CM Sieben, D Sumstad, DM Kadidlo, ... Science translational medicine 3 (83), 83ra41-83ra41, 2011 | 410 | 2011 |
| Phase I/II trial of StemRegenin-1 expanded umbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft JE Wagner, CG Brunstein, AE Boitano, TE DeFor, D McKenna, D Sumstad, ... Cell stem cell 18 (1), 144-155, 2016 | 402 | 2016 |
| Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria JW Lee, A Krasnodembskaya, DH McKenna, Y Song, J Abbott, ... American journal of respiratory and critical care medicine 187 (7), 751-760, 2013 | 400 | 2013 |
| Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units MR Verneris, CG Brunstein, J Barker, ML MacMillan, T DeFor, ... Blood, The Journal of the American Society of Hematology 114 (19), 4293-4299, 2009 | 333 | 2009 |
| Systemic Administration of Human Bone Marrow-Derived Mesenchymal Stromal Cell Extracellular Vesicles Ameliorates Aspergillus Hyphal Extract-Induced Allergic … FF Cruz, ZD Borg, M Goodwin, D Sokocevic, DE Wagner, A Coffey, ... Stem cells translational medicine 4 (11), 1302-1316, 2015 | 229 | 2015 |
| Therapeutic potential of mesenchymal stem cells for severe acute lung injury MA Matthay, BT Thompson, EJ Read, DH McKenna Jr, KD Liu, CS Calfee, ... Chest 138 (4), 965-972, 2010 | 228 | 2010 |
| First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia S Cooley, F He, V Bachanova, GM Vercellotti, TE DeFor, JM Curtsinger, ... Blood advances 3 (13), 1970-1980, 2019 | 207 | 2019 |
| Allogeneic natural killer cells for refractory lymphoma V Bachanova, LJ Burns, DH McKenna, J Curtsinger, ... Cancer immunology, immunotherapy 59, 1739-1744, 2010 | 205 | 2010 |
| Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia S Asmussen, H Ito, DL Traber, JW Lee, RA Cox, HK Hawkins, DF McAuley, ... Thorax 69 (9), 819-825, 2014 | 184 | 2014 |
| Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation DF McAuley, GF Curley, UI Hamid, JG Laffey, J Abbott, DH McKenna, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 306 (9 …, 2014 | 165 | 2014 |
| Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples V Laroche, DH McKenna, G Moroff, T Schierman, D Kadidlo, ... Transfusion 45 (12), 1909-1916, 2005 | 150 | 2005 |
